Immunogenicity and reactogenicity to Haemophilus influenzae type b (Hib) conjugate vaccine among rural Alaska adults

Human Vaccines

Volumn 2, Issue 1, 2006, Pages 24-28

  Dentinger, Catherine M ^a,e   Hennessy, Thomas W ^a   Bulkow, Lisa R ^a   Reasonover, Alisa L ^a   Romero Steiner, Sandra ^a   Holder, Patricia F ^a   Gomez De Leon, Patricia ^b   Carlone, George M ^a   Parks, Debra J ^a   Parkinson, Alan J ^a   Singleton, Rosalyn J ^c   Levine, Orin S ^d   Butler, Jay C ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c ALASKA NATIVE TRIBAL HEALTH CONSORTIUM   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

Alaska Natives; Haemophilus influenzae; Hib; Hib vaccine

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM CARRIER; CHILD; CONTROLLED STUDY; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNOGENICITY; INFANT; INJECTION SITE PAIN; INJECTION SITE SWELLING; MAJOR CLINICAL STUDY; MALE; NEWBORN; OROPHARYNX; RURAL AREA; SERUM BACTERICIDAL ACTIVITY; UNITED STATES; VACCINATION;

EID: 33646346644     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.2.1.2445     Document Type: Article

References (29)

1. Cochi SL, Broome CV, Hightower AW. Immunization of US children with Haemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment. JAMA 1985;253:521-9.
2. Ward JI, Lum MK, Hall DB, Silimperi DR, Bender TR. Invasive Haemophilus influenzae type b disease in Alaska: background epidemiology for a vaccine efficacy trial. J Infect Dis 1986;153:17-26.
3. Barbour ML, Mayon-White RT, Coles C, Crook DW, Moxon ER. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis 1995;171:93-8.
4. http://www.cdc.gov/ncidod/dbmd/abcs/survreports/hib01_provis.pdf
5. Takala AK, Eskola J, Leinonen M, Kayhty H, Nissinen A, Pekkanen E, Makela PH. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis 1991;164:982-6.
6. Murphy TV, Pastor P, Medley F, Osterholm MT, Granoff DM. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J Pediatr 1993;122:517-23.
7. Mohle-Boetani JC, Ajello G, Breneman E, Deaver KA, Harvey C, Plikaytis BD, Farley MM, Stephens DS, Wenger JD. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. Pediatr Infect Dis J 1993;12:589-93.
8. McVernon J, Howard AJ, Slack MP, Ramsay, ME. Long-term impact of vaccination on Haemophilus influenzae type b (Hib) carriage in the United Kingdom. Epidemiol Infect 2004;132:765-7.
9. Galil K, Singleton R, Levine OS, Fitzgerald MA, Bulkow L, Getty M, Perkins BA, Parkinson A. Reemergence of invasive Haemophilus influenzae type B disease in a well-vaccinated population in remote Alaska. J Infect Dis 1999;179:101-6.
10. http://www.healthypeople.gov/document/HTML/Volume1/14Immunization.htm #_Toc494510239
11. Michaels RH, Stonebraker FE, Robbins JB. Use of antiserum agar for detection of Haemophilus influenzae type b in the pharynx. Pediatr Res 1975;9:513-6.
12. Madore DV, Anderson P, Baxter BD, Carlone GM, Edwards KM, Hamilton RG, Holder P, Kayhty H, Phipps DC, Peeters CC, Schneerson R, Siber GR, Ward JI, Frasch CE. Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 1996; 3:84-8.
13. Romero-Steiner S, Fernandez J, Biltoft C, Wohl ME, Sanchez J, Feris J, Balter S, Levine OS, Carlone GM. Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine. Clin Diagn Lab Immunol 2001;8:1115-9.
14. Romero-Steiner S, Spear W, Brown N, Holder P, Hennessy T, Gomez De Leon P, Carlone GM. Measurement of serum bactericidal activity to Haemophilus influenzae type b by using a chromogenic and fluorescent metabolic indicator. Clin Diagn Lab Immunol 2004;11:89-93.
15. Schlesinger Y, Granoff DM. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group. JAMA. 1992;267:1489-94.
16. Käyhty H, Peltola H, Karanko V, Mäkela PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983;147:1100.
17. Fernandez J, Levine OS, Sanchez J, Balter S, LaClaire L, Feris J, Romero-Steiner S. Prevention of Haemophilus influenzae Type b colonization by vaccination: correlation with serum anti-capsular IgG concentration. J Infect Dis 2000;182:1553-6.
18. Bulkow LR, McMahon BJ, Wainwright RB, Parkinson AJ, Wainwright KY and House J. Safety and immunogenicity of a combined hepatitis B virus-Haemophilus influenzae type b vaccine formulation in healthy adults. Arctic Med Res 1993;52:118-26.
19. Englund JA, Glezen WP, Turner C, Harvey J, Thompson C, Siber GR. Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type b vaccines. J Infect Dis 1995;171:99-105.
20. Santosham M, Englund JA, McInnes P, Croll J, Thompson CM, Croll L, Glezen WP, Siber GR. Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants. Pediatr Infect Dis J 2001;20:931-40.
21. Lottenbach KR, Granoff DM, Barenkamp SJ, Powers DC, Kennedy D, Irby-Moore S, Homan SM, Mink CM. Safety and immunogenicity of Haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population. J Am Geriatr Soc 2004;52:1883-7.
22. Sinsalo M, Aittoniemi J, Kayhty H, Vilpo J. Haemophilus influenzae type b (Hib) antibody concentrations and vaccination responses in patients with chronic lymphocytic leukemia: predicting factors for response. Leuk Lymphoma 2002;43:1967-9.
23. Robertson JD, Nagesh K, Jowitt SN, Dougal M, Anderson H, Mutton K, Zambon M, Scarffe JH. Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer 2000;82:1261-5.
24. Molrine DC, Guinan EC, Antin JH, Wheeler C, Parsons SK, Weinstein HJ, McGarigle C, Blanding P, Phillips NR, Ciamarra A, George S, Ambrosino DM. Haemophilus influenzae type b (HIB)-conjugate immunization before bone marrow harvest in autologous bone marrow transplantation. Bone Marrow Transplant 1996;17:1149-55.
25. Guinan EC, Molrine DC, Antin JH, Lee MC, Weinstein HJ, Sallan SE, Parsons SK, Wheeler C, Gross W, McGarigle C, et al. Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Transplantation 1994;57:677-84.
26. Cimaz R, Mensi C, D'Angelo E, Fantola E, Milone V, Biasio LR, Carnelli V, Zanetti AR. Safety and immunogenicity of a conjugate vaccine against Haemophilus influenzae type b in splenectomized and nonsplenectomized patients with Cooley anemia. J Infect Dis 2001;183:1819-21.
27. Steinhoff MC, Auerbach BS, Nelson KE, Vlahov D, Becker RL, Graham NM, Schwartz DH, Lucas AH, Chaisson RE. Antibody responses to Haemophilus influenzae type b vaccines in men with human immunodeficiency virus infection. N Engl J Med; 1991;325:1837-42.
28. Goldsby RA, Kindt TJ, Osborne BA. Immunoglobulins structure and function. Kuby Immunology, 4th Edition. New York: WH. Freeman and Company, 2000:99.
29. Greenberg D, Broides A, Blancovich I, Peled N, Givon-Lavi N, Dagan R. Relative importance of nasopharyngeal versus oropharyngeal sampling of isolation of Streptococcus pneumoniae and Haemophilus influenzae from healthy and sick individuals varies with age. J Clin Microbiol 2004;42:4604-9.